Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 117.27M | 113.86M | 110.94M | 101.23M | 91.30M |
| Total Other Revenue | -- | -- | -- | -- | 1.00K |
| Total Revenue | 117.27M | 113.86M | 110.94M | 101.23M | 91.30M |
| Cost of Revenue | 49.05M | 44.53M | 42.59M | 39.00M | 35.84M |
| Gross Profit | 68.22M | 69.33M | 68.36M | 62.23M | 55.47M |
| SG&A Expenses | 77.90M | 80.97M | 79.82M | 72.60M | 64.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 129.34M | 127.86M | 124.55M | 113.28M | 101.46M |
| Operating Income | -12.08M | -14.00M | -13.61M | -12.05M | -10.16M |
| Income Before Tax | -16.26M | -16.85M | -4.95M | -3.30M | -1.04M |
| Income Tax Expenses | 187.00K | 743.00K | -1.62M | -1.64M | -1.70M |
| Earnings from Continuing Operations | -16.45 | -17.59 | -3.33 | -1.66 | 0.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.45M | -17.59M | -3.33M | -1.66M | 660.00K |
| EBIT | -12.08M | -14.00M | -13.61M | -12.05M | -10.16M |
| EBITDA | -7.85M | -9.91M | -9.70M | -8.34M | -6.98M |
| EPS Basic | -0.12 | -0.13 | -0.02 | -0.02 | 0.00 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.08 | -0.07 | -0.07 |
| EPS Diluted | -0.12 | -0.14 | -0.03 | -0.02 | 0.00 |
| Normalized Diluted EPS | -0.07 | -0.08 | -0.08 | -0.07 | -0.06 |
| Average Basic Shares Outstanding | 553.82M | 525.59M | 518.63M | 497.26M | 475.95M |
| Average Diluted Shares Outstanding | 553.82M | 525.59M | 526.16M | 504.78M | 483.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
